检索

期
标题
作者
卷 96, 编号 5 (2024)
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice
Potapova A., Karateev A., Polishchuk E., Filatova E., Amirdzhanova V., Lila A.
PDF
(Rus)
卷 95, 编号 12 (2023)
Real-world experience with netakimab in the treatment of spondyloarthritis
Meshkov A., Vorobyeva N., Ostapenko V., Pykhtina V., Ruzanova V., Perlova O., Kordyukova I., Naumov A., Khovasova N., Tkacheva O.
PDF
(Rus)
卷 94, 编号 5 (2022)
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs
Korolev M., Letyagina E., Sizikov A., Bogoderova L., Ubshaeva Y., Omelchenko V., Akimova A., Mullagaliev A., Chumasova O., Kurochkina Y.
PDF
(Rus)
卷 95, 编号 12 (2023)
Autoimmunity in rheumatology: A review
Nasonov E.
PDF
(Rus)
卷 87, 编号 5 (2015)
Biological agents and fracture risk
Vetkova E., Dydykina I., Nasonov E.
卷 88, 编号 12 (2016)
Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations
Nasonov E.
PDF
(Rus)
卷 89, 编号 5 (2017)
New horizons in the use of biological agents during pregnancy in patients with rheumatic disease
Shesternya P., Petrova M., Vasilyeva A.
PDF
(Rus)
卷 85, 编号 5 (2013)
Rheumatology in Russia in the early 21st century
Nasonov E.
卷 84, 编号 5 (2012)
RHEUMATOID ARTHRITIS: PROBLEMS AND SIGNIFICANCE OF PERSONALIZED MEDICINE
Nasonov E.
卷 88, 编号 5 (2016)
Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis
Popkova T., Novikova D., Nasonov E.
PDF
(Rus)
卷 81, 编号 6 (2009)
Rituximab treatment of rheumatoid arthritis: new evidence
Nasonov E., Nasonov E.
卷 88, 编号 5 (2016)
Cardiovascular disease in rheumatic diseases
Nasonov E., Popkova T., Novikova D.
PDF
(Rus)
卷 87, 编号 8 (2015)
Use of biological therapy in patients with rheumatoid arthritis in the Republic of Kazakhstan
Nogaeva M., Amanzholova A.
卷 92, 编号 5 (2020)
Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up
Aronova E., Lukina G., Glukhova S., Gridneva G., Kudryavtseva A.
PDF
(Rus)
卷 90, 编号 2 (2018)
Personalized medicine in the treatment of inflammatory bowel diseases
Parfenov A., Knyazev O., Kagramanova A., Fadeeva N.
PDF
(Rus)
卷 85, 编号 5 (2013)
Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases
Moiseev S., Novikov P., Semenkova E., Strizhakov L., Guliaev S., Ianushkevich T., Nikiforova N., Meshkov A., Panasiuk V., Sorokin I., Taranova M., Parfenova S., Dubrovskaia L., Zhabina E., Kuznetsova E., Lopatina I., Bulanov N., Mukhin N.
1 - 16 的 16 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##